Lack of clinical association and effect of peripheral WBC counts on immune cell function test in kidney transplant recipients with T-cell depleting induction and steroid-sparing maintenance therapy

Transplant Immunology

Volumn 30, Issue 2-3, 2014, Pages 88-92

  Sageshima, Junichiro ^a,b   Ciancio, Gaetano ^a,b   Chen, Linda ^a,b   Dohi, Takehiko ^b   El Hinnawi, Ashraf ^b   Paloyo, Siegfredo ^b   Gaynor, Jeffrey J ^a,b   Mattiazzi, Adela ^a,b   Guerra, Giselle ^a,b   Kupin, Warren ^a,b   Roth, David ^a,b   Ruiz, Phillip ^a,b   Burke, George W ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Antibody therapy; Cylex; ImmuKnow; Infection; Kidney transplant; Rejection

Indexed keywords

ALEMTUZUMAB; DACLIZUMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FUNCTION TEST KIT; GRAFT RECIPIENT; HUMAN; IMMUNE FUNCTION TEST; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LOW DRUG DOSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T CELL DEPLETION; BLOOD; COMPARATIVE STUDY; GRAFT REJECTION; IMMUNOLOGY; LYMPHOCYTE DEPLETION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

ADULT; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84896549851     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2014.01.003     Document Type: Article

References (10)

1. Rodrigo E., López-Hoyos M., Corral M., et al. ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis. Liver Transpl 2012, 18(10):1245.
2. Ling X., Xiong J., Liang W., et al. Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis. Transplantation 2012, 93(7):737.
3. Huskey J., Gralla J., Wiseman A.C. Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection. Clin J Am Soc Nephrol 2011, 6(2):423.
4. Serban G., Whittaker V., Fan J., et al. Significance of immune cell function monitoring in renal transplantation after Thymoglobulin induction therapy. Hum Immunol 2009, 70(11):882.
5. Zhou H., Lin J., Chen S., et al. Use of the ImmuKnow assay to evaluate the effect of alemtuzumab-depleting induction therapy on cell mediated immune function after renal transplantation. Clin Exp Nephrol 2013, 17(2):304.
6. Ciancio G., Gaynor J.J., Zarak A., et al. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: four-year analysis. Transplantation 2011, 91(11):1198.
7. Ciancio G., Gaynor J.J., Sageshima J., et al. Randomized trial of dual antibody induction therapy with steroid avoidance in renal transplantation. Transplantation 2011, 92(12):1348.
8. Gupta S., Mitchell J.D., Markham D.W., et al. Utility of the Cylex assay in cardiac transplant recipients. J Heart Lung Transplant 2008, 27(8):817.
9. Sageshima J., Ciancio G., Guerra G., et al. Prolonged lymphocyte depletion by single-dose rabbit anti-thymocyte globulin and alemtuzumab in kidney transplantation. Transpl Immunol 2011, 25(2-3):104.
10. Israeli M., Ben-Gal T., Yaari V., et al. Individualized immune monitoring of cardiac transplant recipients by noninvasive longitudinal cellular immunity tests. Transplantation 2010, 89(8):968.